Update on new treatments for rare ovarian tumours.
Current opinion in obstetrics & gynecology（2023）
摘要
The last few years have exhibited a paradigm shift towards the possibility to develop dedicated trials for ROT, owing to international collaborations supported by institutional networks. Current trials, molecular-driven and based on innovative designs, are highly promising, as they may bring ROT management towards more personalized medicine.
更多查看译文
关键词
academic research,clinical practice,clinical trials,expert networks,rare gynaecological tumours
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要